A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic Stroke

9650M19-148Open (affiliates only)A Randomized, Double-Blind, Placebo-Controlled Proof-of-Concept Study to Assess the Safety and Efficacy of Elezanumab in Acute Ischemic StrokeNCT04309474IndustrialAdultTreatmentOtherEdwardson, MatthewGeorgetown University Medical Center : Micah Hamilton; Lombardi Comprehensive Cancer Center : Micah HamiltonGUMC Neurology15852Micah HamiltonMicah Hamiltonmgh62@georgetown.edu2026.1.0 Build 16 <a href="https://advarra.com" target="_blank">© 2026 Advarra, Inc.</a>